100% focus is on getting the PISCES trial underway and it is the clearest pathway to shareholder value according to Punit. Cutting costs and adding key people to the board to make this happen has been the priority. I'm not worried unless we don't get good trial results. I think we are lined up for commercial success or a buyout on good PISCES results.
News 
Market Data 
Discover 
AI
